Michael Liptay to Predictive Value of Tests
This is a "connection" page, showing publications Michael Liptay has written about Predictive Value of Tests.
Connection Strength
0.350
-
Establishment of a multi-analyte serum biomarker panel to identify lymph node metastases in non-small cell lung cancer. J Thorac Oncol. 2009 Mar; 4(3):338-47.
Score: 0.072
-
Sentinel node mapping in lung cancer: introduction. Semin Thorac Cardiovasc Surg. 2009; 21(4):297.
Score: 0.071
-
Sentinel node mapping in lung cancer: the Holy Grail? Ann Thorac Surg. 2008 Feb; 85(2):S778-9.
Score: 0.067
-
Identification of clinical factors predicting Pleurx catheter removal in patients treated for malignant pleural effusion. Eur J Cardiothorac Surg. 2008 Jan; 33(1):89-94.
Score: 0.066
-
Value of circulating insulin-like growth factor-associated proteins for the detection of stage I non-small cell lung cancer. J Thorac Cardiovasc Surg. 2015 Mar; 149(3):727-34.e1-3; discussion 734.
Score: 0.027
-
Development and validation of a plasma biomarker panel for discerning clinical significance of indeterminate pulmonary nodules. J Thorac Oncol. 2013 Jan; 8(1):31-6.
Score: 0.024
-
Development of a serum biomarker panel predicting recurrence in stage I non-small cell lung cancer patients. J Thorac Cardiovasc Surg. 2012 Dec; 144(6):1344-50; discussion 1350-1.
Score: 0.023